ASCO Guideline: Molecular Testing for Selection of Patients With Lung Cancer for Treatment With Targeted Therapy

This clinical guideline provides evidence-based recommendations for healthcare professionals. It was developed by American Society of Clinical Oncology through systematic review of available evidence and expert consensus.

Document Details

• Issuing Authority: American Society of Clinical Oncology
• Type: Clinical Guideline
• Specialty Area: Oncology & Haematology
• Date: 2023

Access the Full Guideline

View Full Guideline →

Source: American Society of Clinical Oncology. This content is provided for informational purposes. Always refer to the official document for the most current version and recommendations.